Dr Gil Morgan from OncoAlert gives his oncology highlights from social media from day 3 of ASCO 2021.
Alerts cover trials such as KEYNOTE-564, OlympiA, VISION, RELATIVITY-047, JUPITER-02, and CheckMate648.
Dr Morgan ends on a question from a colleague in Brazil asking, why is there a difference in translating clinical trials results to clinical practice depending on subspecialties? Comparing the results of OlympiA to those of Adaura.
You can watch Dr Morgan's previous roundup here
Follow Dr Morgan on twitter: @OncoAlert
Follow ecancer on twitter: @ecancer